Suvi-Katri Leivonen

University of Helsinki

Finland

Research Interests

Explore related searches

Professors in Finland Professors in Immunology Immunology professors in Finland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Oscar Brück

FINLAND

View details

Judit Meszaros Joergensen

Aarhus University

DENMARK

View details

Sirpa Leppä

University of Helsinki

FINLAND

View details

Harald Holte

Senior consultant, head of lymphoma section

University of Oslo

NORWAY

View details

Olav Engebraaten

NORWAY

View details

Ida Monrad Johannsen

Aarhus University

DENMARK

View details

Heli Vajavaara

University of Helsinki

FINLAND

View details

Mette Bjerre

Aarhus University

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Suvi-Katri Leivonen

Research Interests

Explore related searches

Contact this professor

Articles (10)

High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer

Low lymphocyte‐to‐monocyte ratio predicts poor outcome in high‐risk aggressive large B‐cell lymphoma

Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patients

Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment

Prognostic impact of soluble CD163 in patients with diffuse large B-cell lymphoma

Testicular Diffuse Large B-Cell Lymphoma—Clinical, Molecular, and Immunological Features

MicroRNA in combination with HER2-targeting drugs reduces breast cancer cell viability in vitro

miRNA normalization enables joint analysis of several datasets to increase sensitivity and to reveal novel miRNAs differentially expressed in breast cancer

Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma

Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma

Collaborators (8)

Oscar Brück

Judit Meszaros Joergensen

Sirpa Leppä

Harald Holte

Olav Engebraaten

Ida Monrad Johannsen

Heli Vajavaara

Mette Bjerre

Make your next move.